AmpliPhi Biosciences Co. (NYSE:APHB) was the recipient of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 1,308,517 shares, a growth of 56.4% from the October 13th total of 836,702 shares. Based on an average daily trading volume, of 1,239,931 shares, the days-to-cover ratio is currently 1.1 days. Currently, 15.3% of the company’s shares are short sold.

AmpliPhi Biosciences (NYSE APHB) opened at $0.94 on Friday. AmpliPhi Biosciences has a one year low of $0.67 and a one year high of $11.00.

TRADEMARK VIOLATION WARNING: This report was published by Watch List News and is the property of of Watch List News. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at

AmpliPhi Biosciences Company Profile

AmpliPhi Biosciences Corporation is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.

Receive News & Ratings for AmpliPhi Biosciences Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmpliPhi Biosciences Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.